Date: April 27, 2026

Time: 7:30 AM – 3:30 PM

Location: RBC Convention Centre or Online through the University of Manitoba (Hybrid Event)

Cost: FREE!

Description:

HIV Prevention Can’t Wait offers a focused, practical update on HIV prevention in the Prairie provinces. Participants will learn about current HIV trends, available PrEP options, and who is eligible to start PrEP, with clear comparisons of indications, side effects, and limitations.

Don’t miss amazing presentations from experts in the field, such as:

Lenacapavir in Women (PrEP & Treatment) - Dr. Linda-Gall Bekker. Desmond Tutu HIV Centre, University of Cape Town, South Africa.

Cabotegravir in Women (PrEP & Treatment) - Dr. Risa Hoffman, University of California, Los Angeles, USA.

HIV PrEP & Treatment Among People Experiencing Houselessness and People Who Inject Drugs – Dr. Monica Gandhi, University of California San Francisco, San Francisco General Hospital, USA.

Learning Objectives:

By attending this session, participants will be able to:

• Describe available HIV pre-exposure prophylaxis (PrEP) modalities and outline the clinical criteria for initiating PrEP. 
• Compare available PrEP options, including their indications, adverse effects, and limitations.
• Integrate evidence-based principles of effective PrEP delivery into primary care and community-based practice settings.
• Confidently counsel patients at risk of acquiring HIV on PrEP options and initiate PrEP when indicated.

Registration Link: HIV Prevention Can’t Wait: HIV Prevention and Treatment for Women and Priority Populations – Continuing Professional Development – Rady Faculty of Health Sciences